Nervgen Pharma (NGEN) Return on Equity ROE from the fourth quarter 2025 to fourth quarter and annually, average high and low, overall ranking from Dec 31 2025 to - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nervgen Pharma Corp   (NGEN)

Nervgen Pharma 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Nervgen Pharma in the fourth quarter 2025?
Nervgen Pharma Corp recorded a cumulative net loss of $-34 million during 12 months ending in the fourth quarter 2025, resulting in a negative return on equity (ROE) of -1284.25%.

Within the Major Pharmaceutical Preparations industry Nervgen Pharma Corp achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the third quarter 2025 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Equity Change 41.71 % - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -34 0 0 0 0
Return On Equity (TTM) -1284.25 % 0 % 0 % 0 % 0 %
NGEN's Total Ranking # # # # #
Equity (TTM) in Millions 3 3 3 3 2
Seq. Equity Change -4.79 % 0 % 0 % 48.85 % -
Seq. Net Income Change - - - - -

Back to NGEN Management Effectiveness >> NGEN's 5 Years Annual ROE >> Compare NGEN ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





NGEN Annual Return On Equity (Dec 31 2025)
2025



Total Equity in Millions 3 0 0 0 0
Y / Y Equity Change - - - - -
Net Income in Millions -32 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -1245.6 % - - - -

Back to NGEN Management Effectiveness >> NGEN's 5 Years Annual ROE >> Compare NGEN ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NGEN's' Return on Equity at Yahoo Finance
NGEN's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NGEN's Competitors
Subscribers only: Roe for Nervgen Pharma 's Suppliers
Subscribers only: Return On Equity for NGEN's Customers




Companies with similar Return On Equity at Dec 31 2025, within Healthcare Sector ROE

Date modified: 2026-07-07T12:11:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.